Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model

Journal of Oleo Science

Volumn 62, Issue 1, 2013, Pages 21-28

  Kabuto, Hideaki ^a   Yamanushi, Tomoko T ^a   Janjua, Najma ^a   Takayama, Fusako ^b   Mankura, Mitsumasa ^b  

^a KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Fatty acid composition; Oxidative stress; Parkinson's disease; Squalane; Squalene

Indexed keywords

6-HYDROXYDOPAMINE (6-OHDA); ACTIVE OXYGEN; ANTIOXIDANT ENZYME ACTIVITY; FATTY ACID COMPOSITION; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MOUSE MODELS; ORAL ADMINISTRATION; OXIDATIVE DAMAGE; PARKINSON'S DISEASE; SQUALANE; SQUALENE; STRIATUM; SUPEROXIDE DISMUTASE ACTIVITIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRITERPENES;

AMINES; BIOCHEMISTRY; IONIZATION OF GASES; MAMMALS; NEURODEGENERATIVE DISEASES; NEUROPHYSIOLOGY; OXIDATIVE STRESS; OXYGEN; SCAVENGING; TOXICITY;

LINOLEIC ACID;

CATALASE; DOPAMINE; DRUG DERIVATIVE; FATTY ACID; OXIDOPAMINE; SCAVENGER; SQUALANE; SQUALENE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE;

ADMINISTRATION, ORAL; ANIMALS; CATALASE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; FATTY ACIDS; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED ICR; OXIDOPAMINE; PARKINSON DISEASE; SQUALENE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

MLCS; MLOWN;

EID: 84873133207     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.62.21     Document Type: Article

References (30)

1. Halliwell, B. Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 1634-1658 (2006).
2. Tolwani, R. J.; Jakowec, M. W.; Petzinger, G. M.; Green, S.; Waggie, K. Experimental models of Parkinson's disease: insights from many models. Lab. Anim. Sci. 49, 363-371 (1999).
3. Andrew, R.; Watson, D. G.; Best, S. A.; Midgley, J. M.; Wenlong, H.; Petty, R. K. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem. Res. 18, 1175-117 (1993)7.
4. Glinka, Y.; Gassen, M.; Youdim, M. B. H. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 50, 55-66 (1997).
5. Kumar, R.; Agarwal, A. K.; Seth, P. K. Free radicalgenerated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64, 1703-1707 (1995).
6. Kabuto, H.; Yokoi, I.; Iwata-Ichikawa, E.; Ogawa, N. EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity. Neurochem. Res. 24, 1543-1548 (1999).
7. Kabuto, H.; Nishizawa, M.; Tada, M.; Higashio, C.; Shishibori, T.; Kohno, M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanoneprevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem. Res. 30, 325-332 (2005).
8. Kabuto, H.; Tada, M.; Kohno, M. Eugeno [l 2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol. Pharm. Bull. 30, 423-427 (2007).
9. Zih-Rou, H.; Yin-Ku, L.; Jia-You, F. Biological and pharmacological activities of squalene and related compounds: Potential uses in cosmetic dermatology. Molecules. 14, 540-554 (2009).
10. Saint-Leger, D.; Bague, A.; Cohen, E.; Chivot, M. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br. J. Dermatol. 114, 535-542 (1986).
11. Kohno, Y.; Egawa, Y.; Itoh, S.; Nagaoka, S.; Takahashi, M.; Mukai, K. Kinetic study of quenching reaction of single oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim. Biophys. Acta. 1256, 52-56 (1995).
12. Newmark, H. L. Squalene, olive oil, and cancer risk: a review and hypothesis. Cancer Epidemiol. Biomarkers Prev. 6, 1101-1103 (1997).
13. Reddy, L. H.; Couvreur, P. Squalene: A natural triterupene for use in disease management and therapy. Advanced Drug Delivery Reviews. 61, 1412-1426 (2009).
14. Allison, A. C. The mode of action of immunological adjuvants. Dev. Biol. Stand. 92, 3-11 (1998).
15. Allison, A.C. Squalene and squalane emulsions as adjuvants. Methods. 19, 87-93 (1999).
16. Oberley, L. W.; Spitz, D. R. Assays of superoxide dismutase activity in tumor tissue. Method Enzymol. 105, 457-464 (1984).
17. Aebi, H. Catalase in vitro. Method Enzymol. 105, 121-126 (1984).
18. Ohishi, S. Method for determination of lipid peroxides. Saishin Igaku. 33, 660-663 (1987).
19. Lowry, O. J.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Randall R. J. Protein measurement with folin-phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
20. Dexter, D. T.; Wells, F. R.; Lees, A. J.; Agid, F.; Agid, Y. Jenner, P. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830-1836 (1989).
21. Ambani, L. M.; Van Woert, M. H.; Murphy, S. Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32, 114-118 (1975).
22. Kish, S. J.; Morito, C.; Hornykiewicz, O. Glutathion peroxidase activity in Parkinson's diseases. Neurosci. Lett. 58, 343-346 (1985).
23. Riederer, P.; Sofic, E.; Rausch, W. D.; Schmidt, B.; Reynolds, G. P.; Jellinger, K.; Youdim, M. B. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52, 515-520 (1989).
24. Olanow, C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444 (1993).
25. Gylling, H.; Miettinen, T. A. Postabsorptive metabolism of dietary squalene. Atherosclerosis. 106, 169-178 (1994).
26. Strandberg, T. E.; Tilvis, R. S.; Miettinen, T. A. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J. Lipid. Res. 31, 1637-1643 (1990).
27. Senthilkumar, S.; Yogeeta, S. K.; Subashini, R.; Devaki, T. Attenuation of cyclosphamide induced toxicity by squalene in experimental rats. Chem. Biol. Interact. 160, 252-260 (2006).
28. Hauss, T.; Dante, S.; Dencher, N. A.; Haines, T. H. Squalene is in the midplane of the lipid bilayer implications for its function as a proton permeability barrier. Biochim. Biophys. Acta. 1156, 149-154 (2002).
29. Abercormbie, E. D.; Keefe, K. A.; DiFrischia, D. S.; Zigmond, M. J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52, 1655-1658 (1989).
30. Napolitano, A.; Manini, P.; d'Ischia, M. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr. Med. Chem. 18, 1832-1845 (2011).